Top Markets
Coin of the day
Noile-Immune Biotech Inc. Noile-Immune Biotech Inc.

Noile-Immune Biotech Inc.

4893
Rank in Stocks #26571
Established in 2015 and based in Minato, Japan, this company is dedicated to... Established in 2015 and based in Minato, Japan, this company is dedicated to exploring and advancing CAR-T cell technology for use in cancer immunotherapy treatments.
Share Price
$0.91341182
Market Cap
$39.55M
Change (1 day)
-0.71%
Change (1 year)
-26.05%
Country
JP
Trade Noile-Immune Biotech Inc. (4893)

Category

Operating Margin for Noile-Immune Biotech Inc. (4893)
Operating Margin as of 2026 TTM: 0.00%
According to Noile-Immune Biotech Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Noile-Immune Biotech Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
25.72% -
AU
-149.01% -
US
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.